Stephen Tanner

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Nucleic Acid Sequencing. Top assignee: Illumina Corporation. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Tanner. Retrieved from https://idiyas.com/inventor/stephen-tanner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 115(Granted Patents)

Company Filing History:

21 out of 1,227

Illumina Corporation

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Sequencing

Image Analysis

Molecular Index Sets

Phasing Identification

Flow Cell Templates

Fiducials

Error-Correction

Biological Samples

Data Processing

Patterned Objects

Excitation Frequencies

Rotated Patterns

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12620098 - Creating a template of nucleic acid site locations on a flow cell (2026-05-05),

2. 12380561 - Creating a template of nucleic acid site locations on a flow cell (2025-08-05),

3. 12307670 - Analyzing image data from nucleic acid sequencing (2025-05-20),

4. 12223651 - Identifying nucleotides by determining phasing (2025-02-11),

5. 11896944 - System and method with fiducials responding to multiple excitation frequencies (2024-02-13),

6. 11835460 - System and method with fiducials having offset layouts (2023-12-05),

7. 11761035 - Methods and systems for generation and error-correction of unique molecular index sets with heterogeneous molecular lengths (2023-09-19),

8. 11676275 - Identifying nucleotides by determining phasing (2023-06-13),

9. 11605165 - System and methods for identifying nucleotides (2023-03-14),

10. 11427868 - System and method with fiducials of non-closed shapes (2022-08-30),

11. 11308640 - Image analysis useful for patterned objects (2022-04-19),

12. 11262307 - System and method with reflective fiducials for locating or registering locations receiving biological samples in successive cycles of fluorescent imaging (2022-03-01),

13. 11249025 - System and method with fiducials in non-rectilinear layouts (2022-02-15),

14. 10844429 - Methods and systems for generation and error-correction of unique molecular index sets with heterogeneous molecular lengths (2020-11-24),

15. 10689696 - Methods and systems for analyzing image data (2020-06-23),

Title: The Innovative Journey of Inventor Stephen Tanner

Introduction

Stephen Tanner, a prolific inventor based in San Diego, California, holds an impressive portfolio of 18 patents. His work primarily focuses on advancements in molecular analysis and DNA sequencing methodologies. His contributions are notable not only for their technical depth but also for their potential implications in the fields of genetics and biotechnology.

Latest Patents

Among his latest innovations, Tanner has developed methods and systems for identifying nucleotides by determining phasing, which are essential for real-time analysis of image and sequence data generated during DNA sequencing. Additionally, he has created a system and method that employs fiducials responding to multiple excitation frequencies. These fiducial markers, utilized on patterned arrays, enhance detection processes in molecular analysis, providing configurations that boost image detection, processing efficiency, and encoded information retrieval.

Career Highlights

Stephen Tanner's career has been marked by a commitment to innovation within the biotechnology sector. His work at Illumina Corporation places him at the forefront of genetic research and molecular technology, where his developments contribute significantly to advancements in sequencing techniques and diagnostic applications.

Collaborations

Throughout his career, Tanner has collaborated with notable colleagues such as John S. Vieceli and John A. Moon. These partnerships foster an environment of innovation and excellence, leveraging diverse expertise to tackle complex challenges in molecular analysis and sequencing.

Conclusion

In conclusion, Stephen Tanner exemplifies the spirit of innovation through his significant contributions to the field of biotechnology. His patents not only advance scientific knowledge but also pave the way for new applications in DNA sequencing and molecular analysis, illustrating the profound impact that dedicated inventors can have on science and society.

Profile summary based on public USPTO records.